The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients

<table>The changes of hematocrit during the first 5 weeks after CERA use. The changes of hematocrit in 61 hemodialysis patients during the first 5 weeks.  (The mean value and standard deviation of Hct of HD patients are displayed weekly.) </table>

The Scientific World Journal

fig1

Figure 1

Figure 1: The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients 

Figure 1 | The Waveform Fluctuation and the Clinical Factors of the Initial and Sustained Erythropoietic Response to Continuous Erythropoietin Receptor Activator in Hemodialysis Patients 